title: Are low molecular weight heparins able to sensitize chemoresistant tumor cells?
authors.affiliation: Pharmaceutical Department, University of Bonn, Bonn, Germany. dastoelt@uni-bonn.de
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Stölting
authors.forename: Ulrich
authors.initials: U
authors.lastname: Jaehde
authors.forename: Michael
authors.initials: M
authors.lastname: Wiese
authors.forename: Gerd
authors.initials: G
authors.lastname: Bendas
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000187:drug effects; D000925:Anticoagulants / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D015153:Blotting, Western / Q000379:methods; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000187:drug effects; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005434:Flow Cytometry / Q000379:methods; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D000078222:Tinzaparin; D014407:Tumor Cells, Cultured
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000925:Anticoagulants; D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin; D002945:Cisplatin